JP2020513020A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020513020A5 JP2020513020A5 JP2019554995A JP2019554995A JP2020513020A5 JP 2020513020 A5 JP2020513020 A5 JP 2020513020A5 JP 2019554995 A JP2019554995 A JP 2019554995A JP 2019554995 A JP2019554995 A JP 2019554995A JP 2020513020 A5 JP2020513020 A5 JP 2020513020A5
- Authority
- JP
- Japan
- Prior art keywords
- cas
- amino acid
- disease
- complex peptide
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023045624A JP2023078369A (ja) | 2017-04-07 | 2023-03-22 | γｃサイトカイン活性の安定な調節剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762483210P | 2017-04-07 | 2017-04-07 | |
| US62/483,210 | 2017-04-07 | ||
| PCT/US2018/026125 WO2018187499A1 (en) | 2017-04-07 | 2018-04-04 | Stable modulators of gamma-c-cytokine activity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023045624A Division JP2023078369A (ja) | 2017-04-07 | 2023-03-22 | γｃサイトカイン活性の安定な調節剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020513020A JP2020513020A (ja) | 2020-04-30 |
| JP2020513020A5 true JP2020513020A5 (enExample) | 2021-05-13 |
| JP7752929B2 JP7752929B2 (ja) | 2025-10-14 |
Family
ID=63712710
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019554995A Active JP7752929B2 (ja) | 2017-04-07 | 2018-04-04 | γｃサイトカイン活性の安定な調節剤 |
| JP2023045624A Pending JP2023078369A (ja) | 2017-04-07 | 2023-03-22 | γｃサイトカイン活性の安定な調節剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023045624A Pending JP2023078369A (ja) | 2017-04-07 | 2023-03-22 | γｃサイトカイン活性の安定な調節剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210324029A1 (enExample) |
| EP (1) | EP3606940A4 (enExample) |
| JP (2) | JP7752929B2 (enExample) |
| KR (2) | KR102707650B1 (enExample) |
| CN (1) | CN110506050A (enExample) |
| AU (3) | AU2018250210B2 (enExample) |
| CA (1) | CA3054820A1 (enExample) |
| WO (1) | WO2018187499A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2665486T1 (sl) | 2011-01-18 | 2020-07-31 | Bioniz, Llc | Sestavki za moduliranje aktivnosti gama-C-citokina |
| WO2015089217A2 (en) | 2013-12-10 | 2015-06-18 | Bionz, Llc | Methods of developing selective peptide antagonists |
| WO2017062685A1 (en) | 2015-10-09 | 2017-04-13 | Bioniz, Llc | Modulating gamma - c -cytokine activity |
| WO2020227019A1 (en) * | 2019-05-03 | 2020-11-12 | Bioniz, Llc | Modulating the effects of gamma-c-cytokine signaling for the treatment of alopecia and alopecia associated disorders |
| AU2021248679A1 (en) * | 2020-04-02 | 2022-10-27 | Takeda Pharmaceutical Company Limited | ADAMTS13 variant, compositions, and uses thereof |
| CA3186973A1 (en) * | 2020-06-24 | 2021-12-30 | Bioniz, Llc | Antagonistic peptide targeting il-2, il-9, and il-15 signaling for the treatment of cytokine-release syndrome and cytokine storm associated disorders |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7192713B1 (en) * | 1999-05-18 | 2007-03-20 | President And Fellows Of Harvard College | Stabilized compounds having secondary structure motifs |
| JP5322653B2 (ja) | 2005-11-28 | 2013-10-23 | ザイモジェネティクス， インコーポレイテッド | Ｉｌ−２１アンタゴニスト |
| WO2010011313A2 (en) * | 2008-07-23 | 2010-01-28 | President And Fellows Of Harvard College | Ligation of stapled polypeptides |
| ES2620437T3 (es) | 2008-11-17 | 2017-06-28 | Københavns Universitet | Péptidos derivados de IL-4 para la modulación de la respuesta inflamatoria crónica y el tratamiento de enfermedades autoinmunes |
| WO2011008260A2 (en) * | 2009-07-13 | 2011-01-20 | President And Fellows Of Harvard College | Bifunctional stapled polypeptides and uses thereof |
| SI2665486T1 (sl) * | 2011-01-18 | 2020-07-31 | Bioniz, Llc | Sestavki za moduliranje aktivnosti gama-C-citokina |
| WO2017062685A1 (en) * | 2015-10-09 | 2017-04-13 | Bioniz, Llc | Modulating gamma - c -cytokine activity |
-
2018
- 2018-04-04 US US16/603,040 patent/US20210324029A1/en active Pending
- 2018-04-04 CA CA3054820A patent/CA3054820A1/en active Pending
- 2018-04-04 EP EP18780544.5A patent/EP3606940A4/en active Pending
- 2018-04-04 CN CN201880023448.1A patent/CN110506050A/zh active Pending
- 2018-04-04 KR KR1020197032925A patent/KR102707650B1/ko active Active
- 2018-04-04 WO PCT/US2018/026125 patent/WO2018187499A1/en not_active Ceased
- 2018-04-04 JP JP2019554995A patent/JP7752929B2/ja active Active
- 2018-04-04 KR KR1020247030644A patent/KR20240142577A/ko not_active Ceased
- 2018-04-04 AU AU2018250210A patent/AU2018250210B2/en active Active
-
2022
- 2022-07-27 AU AU2022209272A patent/AU2022209272B2/en active Active
-
2023
- 2023-03-22 JP JP2023045624A patent/JP2023078369A/ja active Pending
-
2024
- 2024-06-11 AU AU2024203941A patent/AU2024203941A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020513020A5 (enExample) | ||
| JP2020002154A5 (enExample) | ||
| JP2024029182A5 (enExample) | ||
| US20190194633A1 (en) | Compositions, systems and methods for programming immune cell function through targeted gene regulation | |
| JP2024023294A5 (enExample) | ||
| CN118515780A (zh) | Il-2突变蛋白及其用途 | |
| JP2021507690A5 (enExample) | ||
| JP2023138660A5 (enExample) | ||
| JP2020501550A5 (enExample) | ||
| RS60050B1 (sr) | Kompozicije za modulaciju aktivnosti gama-c-citokina | |
| AU2022209272B2 (en) | Stable modulators of gamma-c-cytokine activity | |
| TW201819628A (zh) | 使用具有工程化穩定表現內源性foxp3基因之cd4 t細胞治療自體免疫疾病的方法 | |
| JP2007514419A5 (enExample) | ||
| AU2023255027A1 (en) | Modulating gamma-C-cytokine activity | |
| JP2011528332A5 (enExample) | ||
| Larochelle et al. | In vivo selection of hematopoietic progenitor cells and temozolomide dose intensification in rhesus macaques through lentiviral transduction with a drug resistance gene | |
| JP2012508698A (ja) | 慢性炎症性応答の調節および自己免疫疾患の処置のためのｉｌ−４由来ペプチド | |
| CA3079405A1 (en) | Compositions and methods for the expansion of hematopoietic stem and progenitor cells | |
| JP2016510213A5 (enExample) | ||
| WO2020002015A1 (en) | Chimeric antigen receptors that bind to prostate specific membrane antigen | |
| CN104127883B (zh) | 以hsp65为表位支架的多t细胞表位结核基因疫苗 | |
| US12479903B2 (en) | CD5 specific T cell receptor cell or gene therapy | |
| EP3517542A1 (en) | Dendritic-cell-targeted peptide, fusion peptide utilizing said peptide, and vaccine utilizing said fusion peptide | |
| EP3603659B1 (en) | Pharmaceutical composition for use in prevention or treatment of inflammatory respiratory disease, with fusion protein of cell permeable peptide and ctctla4 peptide contained as effective ingredient therein | |
| CN102206667B (zh) | 重组质粒pET32a-hIL-23R-CHR及其构建表达 |